Medical News

RSS
Study highlights uncertain value of tachypnea at triage

Study highlights uncertain value of tachypnea at triage

Vulvodynia confers risk for other chronic pain syndromes

Vulvodynia confers risk for other chronic pain syndromes

Chemotherapy is appropriate adjunct to surgery for oral melanoma in dogs

Chemotherapy is appropriate adjunct to surgery for oral melanoma in dogs

Researchers call for digital rectal exam revival

Researchers call for digital rectal exam revival

Plasma exchange is beneficial additive to optic neuritis treatment

Plasma exchange is beneficial additive to optic neuritis treatment

Hospice cancer patients adhere well to pain meds

Hospice cancer patients adhere well to pain meds

High BMI linked to poor outcomes after prostatectomy and ADT

High BMI linked to poor outcomes after prostatectomy and ADT

Old cardiac drug performs new tricks

Old cardiac drug performs new tricks

‘Green’ disinfectant shows promise against hospital-acquired infections

‘Green’ disinfectant shows promise against hospital-acquired infections

Steroid induced Cushing’s warning

Steroid induced Cushing’s warning

Technology for assessing Bradykinesia response to novel therapies in Parkinson’s Disease to be developed by Great Lakes NeuroTechnologies

Technology for assessing Bradykinesia response to novel therapies in Parkinson’s Disease to be developed by Great Lakes NeuroTechnologies

Prostate cancer cells can be killed by theranostic imaging without harming healthy cells

Prostate cancer cells can be killed by theranostic imaging without harming healthy cells

GTx reports revenue of $1.6 million for second quarter 2012

GTx reports revenue of $1.6 million for second quarter 2012

Strategies that encourage lifestyle modifications could help manage hypertension

Strategies that encourage lifestyle modifications could help manage hypertension

Advanced Radiology to offer Amyvid for detection of AD

Advanced Radiology to offer Amyvid for detection of AD

Bristol-Myers Squibb completes tender offer for all outstanding shares of Amylin

Bristol-Myers Squibb completes tender offer for all outstanding shares of Amylin

Omeros completes enrollment in first of two OMS103HP Phase 3 meniscectomy trials

Omeros completes enrollment in first of two OMS103HP Phase 3 meniscectomy trials

Clovis Oncology reports net loss of $15.7 million for second quarter 2012

Clovis Oncology reports net loss of $15.7 million for second quarter 2012

First Edition: August 8, 2012

First Edition: August 8, 2012

APCER Pharma updates and enhances its website

APCER Pharma updates and enhances its website

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.